Status:
TERMINATED
Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic Diseases
Lead Sponsor:
Washington University School of Medicine
Conditions:
Anemia, Sickle Cell
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators plan to obtain skin and blood samples from healthy volunteers and patients with a benign, inherited hematologic disease to use for research to use homologous recombination to correct...
Detailed Description
* To obtain skin biopsy samples from normal healthy volunteers and patients with a benign, inherited hematologic disease, such as sickle cell anemia, to create induced pluripotent stem cells. Pluripot...
Eligibility Criteria
Inclusion
- Age ≥ 18.
- No active systemic skin infection at biopsy site.
- No allergy to lidocaine or other local anesthetics
Exclusion
- ALL PATIENTS
- History of a bleeding disorder, easy bleeding, or bruising.
- Inability or unwillingness to provide informed consent.
- SICKLE CELL PATIENTS
- Platelets ≤ 50,000
- INR ≥ 1.5
- Currently bing given intravenous heparin
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00840567
Start Date
February 1 2009
End Date
October 1 2010
Last Update
July 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110